Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients
- 30 November 1992
- journal article
- case report
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 7 (8), 496-498
- https://doi.org/10.1016/0885-3924(92)90137-7
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Treatment of diarrhoea due to enterocolic fistula with octreotide in a terminal cancer patientPalliative Medicine, 1992
- Analgesic effect of octreotide in headache associated with acromegaly is not mediated by opioid mechanisms. Case reportPain, 1991
- Intrathecal octreotide for cancer painThe Lancet, 1990
- Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome.Gut, 1989
- Pharmacokinetics of SMS 201-995 in Healthy SubjectsScandinavian Journal of Gastroenterology, 1986
- MEDICAL MANAGEMENT OF INTESTINAL OBSTRUCTION IN PATIENTS WITH ADVANCED MALIGNANT DISEASEThe Lancet, 1985